NOLA.com: First Louisiana patient to receive sickle cell gene therapy heads home after 6 weeks in hospital
Learn about the groundbreaking gene therapy for sickle cell disease at Manning Family Children's Hospital in Louisiana, providing hope for a "functional cure".
First Louisiana patient to receive sickle cell gene therapy heads home after 6 weeks in hospital
13NEWSNOW.com: Louisiana’s 1st sickle cell gene therapy patient heads home after historic treatment
Louisiana’s 1st sickle cell gene therapy patient heads home after historic treatment
Medical Xpress: Gene therapy for sickle cell and β-thalassemia works by disrupting three-dimensional genome structure
Scientists at St. Jude Children's Research Hospital and Northwestern University identified a previously unknown treatment opportunity for sickle cell disease and β-thalassemia. The discovery, ...
Gene therapy for sickle cell and β-thalassemia works by disrupting three-dimensional genome structure
In December 2020, the New England Journal of Medicine published a paper titled CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia, marking an exciting new chapter in the treatment of ...
Forbes: Novel Access Model For Sickle Cell Disease Gene Therapy Could Be Template
Novel Access Model For Sickle Cell Disease Gene Therapy Could Be Template
Forbes: Flipping The Switch And Turning On New Sickle Cell And Thalassemia Therapies
Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine A new chapter is unfolding for patients with sickle cell ...
Flipping The Switch And Turning On New Sickle Cell And Thalassemia Therapies
SAN DIEGO — A newly approved gene therapy product for sickle cell disease, lovotibeglogene autotemcel (lovo-cel, marketed as Lyfgenia), led to durable disease remissions for up to 5 years and almost ...